These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36743138)

  • 1. Hypofractionated Radiation Versus Conventional Fractionated Radiation: A Network Analysis.
    Arjmand B; Rezaei-Tavirani M; Hamzeloo-Moghadam M; Razzaghi Z; Khodadoost M; Okhovatian F; Zamanian-Azodi M; Ansari M
    J Lasers Med Sci; 2022; 13():e39. PubMed ID: 36743138
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of the SRC Inhibition Role in the Efficacy of Breast Cancer Radiotherapy.
    Shahrokh S; Mansouri V; Razzaghi M
    J Lasers Med Sci; 2019; 10(Suppl 1):S18-S22. PubMed ID: 32021668
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial.
    de Vries KC; Wortel RC; Oomen-de Hoop E; Heemsbergen WD; Pos FJ; Incrocci L
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):108-115. PubMed ID: 31593756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing Albumin and Interleukin 6 as Common Critical Dysregulated Proteins Between Migraine and Gliosarcoma.
    Arjmand B; Mansouri V; Hamzeloo Moghadam M; Tavirani SR
    Basic Clin Neurosci; 2023; 14(2):185-191. PubMed ID: 38107530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introducing critical proteins related to liver ischemia/reperfusion injury.
    Arjmand B; Khodadoost M; Jahani Sherafat S; Rezaei Tavirani M; Ahmadi N; Rezaei Tavirani S
    Gastroenterol Hepatol Bed Bench; 2024; 17(1):87-92. PubMed ID: 38737933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated Adjuvant Radiation Therapy Is Effective for Patients With Lymph Node-Positive Breast Cancer: A Population-Based Analysis.
    Koulis TA; Nichol AM; Truong PT; Speers C; Gondara L; Tyldesley S; Lohrisch C; Weir L; Olson RA
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1150-1158. PubMed ID: 32721421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Differential Expression Proteins of Paclitaxel-Treated Lung Adenocarcinoma Cell A549 Using Tandem Mass Tag-Based Quantitative Proteomics.
    Zheng W; Xu S
    Onco Targets Ther; 2020; 13():10297-10313. PubMed ID: 33116610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
    Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
    Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation Therapy in Patients With Brain Cancer: Post-proteomics Interpretation.
    Asadzadeh-Aghdaei H; Okhovatian F; Razzaghi Z; Heidari M; Vafaee R; Nikzamir A
    J Lasers Med Sci; 2019; 10(Suppl 1):S59-S63. PubMed ID: 32021675
    [No Abstract]   [Full Text] [Related]  

  • 11. A proteomic investigation of isogenic radiation resistant prostate cancer cell lines.
    Kurganovs N; Wang H; Huang X; Ignatchenko V; Macklin A; Khan S; Downes MR; Boutros PC; Liu SK; Kislinger T
    Proteomics Clin Appl; 2021 Sep; 15(5):e2100037. PubMed ID: 34152685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Radioresistant Biomarkers in Nasopharyngeal Carcinoma Patients Via Protein-Protein Interaction Network Analysis.
    Rezaei Tavirani M; Okhovatian F; Rostami Nejad M; Arjmand B; Razzaghi Z
    J Lasers Med Sci; 2021; 12():e76. PubMed ID: 35155161
    [No Abstract]   [Full Text] [Related]  

  • 13. Conventional versus hypofractionated postmastectomy radiotherapy: a report on long-term outcomes and late toxicity.
    Chitapanarux I; Klunklin P; Pinitpatcharalert A; Sripan P; Tharavichitkul E; Nobnop W; Onchan W; Chakrabandhu S; Jia-Mahasap B; Euathrongchit J; Wannasopha Y; Srisuwan T
    Radiat Oncol; 2019 Oct; 14(1):175. PubMed ID: 31610801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of moderate hypofractionation with volumetric modulated arc therapy versus conventional 3D-radiotherapy after radical prostatectomy.
    Moll M; D'Andrea D; Zaharie A; Grubmüller B; Paschen C; Zehetmayer S; Shariat SF; Widder J; Goldner G
    Strahlenther Onkol; 2022 Aug; 198(8):719-726. PubMed ID: 35284951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
    Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
    Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderately hypofractionated versus conventionally fractionated radiation therapy with temozolomide for young and fit patients with glioblastoma: an institutional experience and meta-analysis of literature.
    Chidley P; Shanker M; Phillips C; Haghighi N; Pinkham MB; Whittle JR; Sia J
    J Neurooncol; 2022 Nov; 160(2):361-374. PubMed ID: 36355260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer: long-term hospital-related morbidity from cardiac causes.
    Chan EK; Woods R; McBride ML; Virani S; Nichol A; Speers C; Wai ES; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):786-92. PubMed ID: 24606848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Highlighted Role of GAPDH and Nitric-Oxide Synthase Regulator Activity in Proton Beam Irradiated Melanoma BLM Cells.
    Zadeh-Esmaeel MM; Shahrokh S; Zamanian Azodi M; Ahmadi N
    J Lasers Med Sci; 2019; 10(Suppl 1):S68-S72. PubMed ID: 32021677
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and characterization of biomarkers and their functions for docetaxel-resistant prostate cancer cells.
    Deng L; Gu X; Zeng T; Xu F; Dong Z; Liu C; Chao H
    Oncol Lett; 2019 Sep; 18(3):3236-3248. PubMed ID: 31452801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study.
    Sanguineti G; Giannarelli D; Petrongari MG; Arcangeli S; Sangiovanni A; Saracino B; Farneti A; Faiella A; Conte M; Arcangeli G
    Radiat Oncol; 2019 Jan; 14(1):23. PubMed ID: 30700317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.